SCHEMBL7986259

SCHEMBL7986259

CCC(C)N(N)OC(=O)c1cccc2nnsc12

nearest known ligand 0.34

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MAPT P10636 7/20 0.34
SMN1; SMN2 Q16637 5/20 0.34
ILK Q13418 2/20 0.33
KDM4E B2RXH2 1/20 0.32
GAA P10253 1/20 0.32
KMT2A Q03164 1/20 0.32
ATM Q13315 1/20 0.32
TP53 P04637 2/20 0.32
ALDH1A1 P00352 1/20 0.32
NPY5R Q15761 1/20 0.32
ADRA1A P35348 1/20 0.31
LMNA P02545 2/20 0.31
NPC1 O15118 2/20 0.30
RAB9A P51151 2/20 0.30
HSD17B10 Q99714 1/20 0.30
MAPK1 P28482 1/20 0.30
POLB P06746 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3743917 0.82 ATM (0.32) MAPTSMN1; SMN2KDM4EKMT2AATM
SCHEMBL9088391 0.80 ADRA1A (0.41) MAPTSMN1; SMN2KDM4EGAAKMT2A
1,2,3-Benzothia-Diazole-7-Carboxylic Acid SCHEMBL7986261 0.77 KMT2A (0.36) MAPTSMN1; SMN2KDM4EGAAKMT2A
SCHEMBL543646 0.77 MAPT (0.49) MAPTSMN1; SMN2ILKKDM4EGAA
SCHEMBL9087862 0.76 TSHR (0.53) MAPTSMN1; SMN2ILKKDM4EGAA
SCHEMBL9089945 0.76 NPC1 (0.44) MAPTSMN1; SMN2KDM4EKMT2ATP53
SCHEMBL4031502 0.74 GAA (0.44) MAPTSMN1; SMN2KDM4EGAAKMT2A
SCHEMBL4203207 0.74 ALDH1A1 (0.55) MAPTSMN1; SMN2KDM4ETP53ALDH1A1
SCHEMBL9668606 0.73 MEN1 (0.40) MAPTSMN1; SMN2KDM4EGAAKMT2A
SCHEMBL7183586 0.73 MAPT (0.37) MAPTSMN1; SMN2ILKGAATP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6262342-B1 CHEMICALLY REGULATABLE DNA SEQUENCES DERIVED FROM 5' REGION OF GENES ENCODING PATHOGENESIS RELATED PROTEINS CAPABLE OF REGULATING TRANSCRIPTION OF AN ASSOCIATED DNA SEQUENCE IN PLANTS/TISSUES, CHIMERIC CONSTRUCTS, AND TRANSGENIC PLANTS NOVARTIS FINANCE CORPORATION 2001-07-17 US disclosed
US-5880328-A ANTI-PATHOGENIC SEQUENCES DERIVED FROM NOVEL CDNAS CODING FOR PR PROTEINS WHICH CAN BE GENETICALLY ENGINEERED AND TRANSFORMED INTO PLANTS TO CONFER ENHANCED RESISTANCE TO DISEASE NOVARTIS FINANCE CORPORATION (US) 1999-03-09 US disclosed
US-5847258-A DNA encoding β-1,3-glucanases NOVARTIS FINANCE CORPORATION (US) 1998-12-08 US disclosed